http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103655542-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 |
filingDate | 2013-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103655542-B |
titleOfInvention | Ampelopsin suppresses the application in the preparation of ferrum tune element expression in preparation |
abstract | The invention provides ampelopsin Myricetin and prepare the application in the preparation suppressing ferrum to adjust plain Hepcidin to express, concrete, described ampelopsin can be used for dietary supplement or the medicine that preparation prevents and treats chronic inflam matory anemia (ACI), intractable iron deficiency anemia (IRIDA) or renal anemia.Beneficial effect of the present invention is mainly reflected in: the invention provides ampelopsin and preparing the application in the preparation suppressing ferrum to adjust plain Hepcidin to express, provide theoretical foundation for ampelopsin improves Hepcidin rising property disease, particularly the medicament research and development of chronic inflam matory anemia and iron deficiency anemia is provided the foundation. |
priorityDate | 2013-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 805.